STAT3 and neoplasm: Following treatment with 5-FU, the HCCR and p-STAT3 levels in tumours developed from HCCR-shRNA1-transfected cells were significantly decreased compared with those in the tumours developed from control shRNA-transfected cells (P < 0.05; Fig. 6B).